| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.12 | 0.5 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.11 | 0.5 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |